Skip to search formSkip to main contentSkip to account menu

aplysinopsin

Known as: 4-Imidazolidinone, 2-imino-5-(1H-indol-3-ylmethylene)-1,3-dimethyl- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Tryptophan
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Mutagenic, genotoxic and cytotoxic studies of invasive corals Tubastraea coccinea and Tubastraea tagusensis
The high diversity of species in the marine environment gives rise to compounds with unique structural patterns not found as… 
2014
2014
Raman spectroscopic study of antioxidant pigments from cup corals Tubastraea spp.
Chemical investigation of nonindigenous Tubastraea coccinea and T. tagusensis by Raman spectroscopy resulted in the… 
2012
2012
Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B.
2011
2011
Synthesis and In Vitro Screening of Novel Heterocyclic Compounds as Potential Breast Cancer Agents
Breast cancer is one of the most common non-cutaneous type of cancer in women in worldwide and a leading cause of cancer-related… 
2010
2010
Microwave assisted synthesis and in vitro cytotoxicities of substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl)methylene-1-methyl-1H-imidazol-4(5H)-ones against human tumor cell lines.
Highly Cited
2009
Highly Cited
2009
Discovery of novel antileishmanial agents in an attempt to synthesize pentamidine-aplysinopsin hybrid molecule.
In an attempt to synthesize pentamidine-aplysinopsin hybrid molecule 25, a lead molecule 8 (containing Z-configured aplysinopsin… 
1977
1977
Aplysinopsin: antineoplastic tryptophan derivative from the marine sponge Verongia spengelii.
: Bioassay-guided fractionation of the aqueous alcoholic extract of the marine sponge Verongia spengelii for tumor inhibitory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)